Literature DB >> 34308939

Generation of a quenched phosphonate activity-based probe for labelling the active KLK7 protease.

Evangelos Bisyris1, Eleni Zingkou1, Golfo G Kordopati1, Minos Matsoukas1, Plato A Magriotis1, Georgios Pampalakis2, Georgia Sotiropoulou1.   

Abstract

Kallikrein 7 (KLK7) is a chymotrypsin-like serine protease with established roles in skin diseases like the rare Netherton syndrome, an overdesquamating and inflammatory condition, but also common atopic dermatitis, and a potential drug target for these and possibly other diseases. Nevertheless, tools to determine the active KLK7 enzyme are not available. Here, a mixed alkyl aryl phosphonate quenched activity-based probe that detects the active KLK7 was developed and evaluated in vitro. This KLK7-qABP can potentially be used to monitor KLK7 activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34308939     DOI: 10.1039/d1ob01273h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

Review 1.  Activity-Based Probes for Proteases Pave the Way to Theranostic Applications.

Authors:  Georgia Sotiropoulou; Eleni Zingkou; Evangelos Bisyris; Georgios Pampalakis
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

2.  Novel specific activity-based probes validate KLK proteases as druggable targets.

Authors:  Georgia Sotiropoulou; Eleni Zingkou; Georgios Pampalakis
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

3.  Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling.

Authors:  Exequiel O J Porta; Jaime A Isern; Karunakaran Kalesh; Patrick G Steel
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.